CDK8-IN-11
CDK8-IN-11 is a potent and selective CDK8 inhibitor with an IC50 value of 46 nM. CDK8-IN-11 inhibits WNT/β-catenin signaling pathway. CDK8-IN-11 can be used in the research of colon cancer[1].
Product Specifications
CAS Number
[2839338-28-0]
UNSPSC
12352005
Target
CDK; Wnt; β-catenin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk8-in-11.html
Purity
98.20
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(C(F)(F)F)=C1)NC2=CC=C(OC3=CC=C(N)N=C3)C=C2
Molecular Formula
C19H15F3N4O2
Molecular Weight
388.34
References & Citations
[1]Yao Yao Yan, et al. Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy. J Med Chem. 2022 Sep 20.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
038350-ML550 100 µL
MEKK4, ID (C1081) (MAP3K4, KIAA0213, MAPKKK4, MEKK4, MTK1, Mitogen-activated protein kinase kinase kinase 4, MAP three kinase 1, MAPK/ERK kinase kinase 4) (MaxLight 550) discontinued
Ask
View Details 
MBS963384-01 0.05 mg (E-Coli)
Recombinant Pig Platelet-derived growth factor subunit B (PDGFB)
Ask
View Details MBS963384-02 0.2 mg (E-Coli)
Recombinant Pig Platelet-derived growth factor subunit B (PDGFB)
Ask
View Details